Melanotan 1

Melanotan 1 (Afamelanotide) is a synthetic analog of α-melanocyte–stimulating hormone (α-MSH). It acts as a melanocortin-1 receptor (MC1R) agonist, stimulating eumelanin production in melanocytes.

  • Sunlight Tolerance: 70% increase in pain-free sun exposure in EPP patients
  • Photoprotection: 50% fewer phototoxic reactions vs placebo
  • Quality of Life: Greater outdoor activity participation and lifestyle improvement
  • Skin Pigmentation: Sustained eumelanin production, providing UV protection and reduced DNA damage
  • First Effective EPP Treatment: Clinically significant reduction in phototoxicity symptoms
  • Safety & Tolerability: Well-tolerated; mild adverse effects reported
  1. Langendonk, J.G., et al. (2015). “Afamelanotide for Erythropoietic Protoporphyria.” New England Journal of Medicine, 373(1), 48–59. DOI link
  2. Biolcati, G., et al. (2015). “Long‐term observational study of afamelanotide in 115 patients with EPP.” British Journal of Dermatology, 172(6), 1601–1612.
  3. Wensink, D., et al. (2020). “Association of Afamelanotide With Improved Outcomes in EPP Patients.” JAMA Dermatology, 156(5), 570–575.
  4. Kim, E.S., & Garnock-Jones, K.P. (2016). “Afamelanotide: A Review in EPP.” American Journal of Clinical Dermatology, 17(2), 179–185.
  5. Minder, E.I., et al. (2017). “Pharmacokinetics and Pharmacodynamics of Afamelanotide.” Clinical Pharmacokinetics, 56(8), 815–823.

$66.00

Per Unit
In stock

Free Shipping on All Orders $1000+